Erschienen in:
02.08.2022 | Original Research Article
Human mast cells induce osteoclastogenesis through cell surface RANKL
verfasst von:
Chun Wai Ng, Ben Chung Lap Chan, Chun Hay Ko, Issan Yee San Tam, Sze Wing Sam, Clara Bik San Lau, Ping Chung Leung, Hang Yung Alaster Lau
Erschienen in:
Inflammation Research
|
Ausgabe 10-11/2022
Einloggen, um Zugang zu erhalten
Abstract
Objectives
We employed the co-culture of CD34+ stem cell-derived human mast cells (HMC) and human monocyte-derived osteoclast precursors to evaluate if mast cells contribute to the pathogenesis of osteoporosis through regulation of osteoclast proliferation and activation.
Methods
Mature HMC and osteoclast precursors were cultured from monocytes isolated from human buffy coat. The osteoclast precursors were incubated with HMC or receptor activator of nuclear factor kappa-B ligand (RANKL) for a week prior to determination of osteoclast maturation through characterization by their morphology and tartrate resistant acid phosphatase (TRAP) expression. The bone absorption activity was determined by pit formation on osteo-assay plate.
Results
Mature osteoclasts were identified following co-culture of osteoclast precursors with HMC for one week in the absence of RANKL and they were capable of bone resorption. These actions of HMC on osteoclasts were not affected by mast cell activators such anti-IgE or substance P but could be reversed by osteoprotegerin (OPG) in the co-culture system suggesting the involvement of RANKL. The expression of RANKL on the cell surface of HMC was confirmed by flow cytometry and the density was not affected by activation of HMC.
Conclusion
Our study provided direct evidence confirming the initiation of osteoclast proliferation and activation by mast cells through cell surface RANKL suggesting that mast cells may contribute to bone destruction in pathological conditions such as osteoporosis.